Clinical trial

Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

NCT00079495

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-07-01

PhasePHASE2

Study timeline

Study start (unknown)2003-07-01Date precision: month

Registry last updated2008-03-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

NBI-5788DRUG

Sponsors & collaborators

Neurocrine Bioscienceslead sponsor

Immune Tolerance Network (ITN)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00079495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.